← Volver a resultados
Ficha bibliográfica · Consulta y acceso
Artículo

Combined exposure risk of emamectin benzoate and cyantraniliprole mixture to nonalcoholic fatty liver disease

Yuying Liu et al · Elsevier · 2026

Acceso abierto disponible
Lectura rápida. Revisá los datos básicos del recurso y luego accedé al contenido desde el botón principal. En esta ficha solo se muestra la información necesaria para identificar la obra, citarla y abrirla.

Acceso al recurso

Entrá al contenido desde la opción principal o elegí otra fuente disponible.

Acceso principal

Acceso abierto disponible

Recurso identificado como acceso abierto, sin confirmar automáticamente si es texto completo directo.
Abrir recurso

Resumen

Descripción general del contenido del recurso.

Evidence links pesticides to nonalcoholic fatty liver disease (NAFLD), but the combined effects of dietary pesticide residue mixture exposure on NAFLD remain poorly documented. This study employed a 42-day subchronic exposure in mice at the National Estimated Daily Intake (NEDI), calculated from the residue levels of emamectin benzoate and cyantraniliprole detected in the 290 collected samples of rice, maize, tomato, cowpea, and cotton. Histopathological and biochemical analyses revealed that subchronic co-exposure to emamectin benzoate and cyantraniliprole increased NAFLD risk, as evidenced by abdominal fat accumulation, pathological alterations, inflammatory responses, oxidative injury, and glucose tolerance impairment in mice. Integrated omics analyses suggest that the observed synergism is driven primarily by disruptions in lipid and glucose metabolism, with significant contributions from the PPAR pathway. These findings suggest a potential synergistic effect of emamectin benzoate and cyantraniliprole mixture exposure on NAFLD risk, highlighting the need to update pesticide mixture risk assessments.

Cómo citar

Elegí el formato que necesitás y copiá la referencia al portapapeles.

APA 7

al, Y. L. E. (2026). Combined exposure risk of emamectin benzoate and cyantraniliprole mixture to nonalcoholic fatty liver disease. https://doi.org/10.1016/j.ecoenv.2026.120116

MLA

al, Yuying Liu et. "Combined exposure risk of emamectin benzoate and cyantraniliprole mixture to nonalcoholic fatty liver disease." 2026. https://doi.org/10.1016/j.ecoenv.2026.120116.

Chicago

al, Yuying Liu et. 2026. "Combined exposure risk of emamectin benzoate and cyantraniliprole mixture to nonalcoholic fatty liver disease.". https://doi.org/10.1016/j.ecoenv.2026.120116.

Harvard

al, Y. L. E. 2026, Combined exposure risk of emamectin benzoate and cyantraniliprole mixture to nonalcoholic fatty liver disease, Elsevier, available at: https://doi.org/10.1016/j.ecoenv.2026.120116 [Accessed 29 Jun. 2026].

Compartir e imprimir

Guardá la ficha, copiá su enlace permanente o imprimila como PDF.

Exportar referencia

Si usás un gestor bibliográfico, podés exportar el registro en los formatos más comunes.

Detalles del recurso

Información bibliográfica útil para confirmar que se trata del material correcto.

Título
Combined exposure risk of emamectin benzoate and cyantraniliprole mixture to nonalcoholic fatty liver disease
Autor / colaboradores
Yuying Liu et al
Editorial
Elsevier
Año de publicación
2026
ISSN
0147-6513
ISSN
0147-6513
Idioma
eng

Materias

Explorá otros recursos relacionados a partir de estas materias.

Copiado